Meeting Banner
Abstract #2757

Liver health outcome of chronic hepatic steatosis: an interim analysis of the Dallas Heart Study cohort

Sujoy Mukherjee1, Jarett Berry2, Carlos Duncker3, Ian Jason Neeland4, Amit Singal2, Viktoria Topper1, and Takeshi Yokoo1
1Department of Radiology and Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, United States, 2Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States, 3Perspectum, Oxford, United Kingdom, 4University Hospitals Cleveland Medical Center, Cleveland, OH, United States


The natural history of hepatic steatosis and risk factors for the development of advanced chronic liver disease (CLD) are unknown. This interim analysis of 191 subjects in the Dallas Heart Study longitudinal cohort shows that having hepatic steatosis (defined as proton-density fat fraction >5%) at the baseline exam was significantly associated with development of advanced CLD (defined as corrected liver T1 ≥ 800msec) 10-20 years later, with CLD prevalence of 38.8% and 16.9% in the steatosis vs. non-steatosis cohort (p<0.001). The baseline overweight or obesity status also appears to be associated with advanced CLD, independent of having steatosis at baseline.

This abstract and the presentation materials are available to members only; a login is required.

Join Here